Valeant Pharmaceuticals Appoints President of Valeant Pharmaceuticals International
ALISO VIEJO, Calif., March 19 /PRNewswire-FirstCall/ -- Valeant
Pharmaceuticals (NYSE: VRX ) today announced that it has appointed Dr. Bhaskar Chaudhuri to the position of President, Valeant
Pharmaceuticals International, effective March 10, 2009. In this role, Dr. Chaudhuri will assume respons...
Three Rivers Pharmaceuticals(R), LLC Acquires Hepatitis C Drug Infergen(R) from Valeant Pharmaceuticals
CRANBERRY TOWNSHIP, Pa., Jan. 14 /PRNewswire/ -- Three Rivers
Pharmaceuticals, LLC finalized acquisition of the hepatitis C drug Infergen
Pharmaceuticals International (NYSE: VRX ). Valeant
receiving $91 million from Three Rivers for the procurement.
"Adding Infergen to our ...
Sanofi-Aventis Recognized for Workplace Efforts to Prevent Cancer
...ncology Nursing Society, OSI Pharmaceuticals, Pfizer, PhRMA, PPD, Quintiles Transnational, SAS Institute, The University of North Dakota, US Oncology, valeant
Pharmaceuticals, Vanderbilt-Ingram Cancer Center, Virtua Health and The Wistar Institute.
About the CEO Roundtable on Cancer
The CEO Round...
Valeant Pharmaceuticals Reports Second Quarter Financial Results
...SO VIEJO, Calif., Aug. 4 /PRNewswire-FirstCall/ -- valeant
Pharmaceuticals International (NYSE: VRX ) today... Conference Call and Webcast Information:
will host a conference call and a live Internet we...ww.valeant.com .
Pharmaceuticals International (NYSE: VRX ) is a ...
Valeant to Acquire Tecnofarma, A Mexican Generic Company
...O VIEJO, Calif., July 29 /PRNewswire-FirstCall/ -- valeant
Pharmaceuticals International (NYSE: VRX ) annou...ment and private label markets - two segments that valeant
Mexico does not currently serve in any material wa...60,000 sq. ft. manufacturing plant that will allow valeant
Latin America to reduce its dependence upon third ...
Valeant Pharmaceuticals to Announce 2009 Second Quarter Results on August 4, 2009
...ations section at www.valeant.com.
Pharmaceuticals International (NYSE: VRX ) is a m...neurology and dermatology. More information about valeant
can be found at www.valeant.com .
AMN Healthcare Names New Chief Financial Officer
... most recent position was that as CFO and Executive Vice President (EVP) at valeant
Pharmaceuticals International, a specialty pharmaceutical company. Bailey joined valeant
in 2002 and was instrumental in restructuring the company to focus on its c...
New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report
...rporation, Tibotec Pharmaceuticals Ltd., Tripep AB, Toray Industries, Inc., valeant
Pharmaceuticals International, and Vertex Pharmaceuticals, Inc. Market data...7
Tripep AB (Sweden) II-77
Toray Industries, Inc. (Japan) II-77
Pharmaceuticals International (USA) II-78
Vertex Pharmaceuticals, Inc. ...
Richard A. Meier Appointed to STAAR Surgical Board of Directors
...tive vice president and chief financial officer of valeant
Pharmaceuticals International (formerly ICN Pharmaceuticals, Inc.). Before joining valeant
Pharmaceuticals, Mr. Meier was a senior vice presi...& Co. Inc. in New York from 1996 until joining valeant
Pharmaceuticals in 1998. Prior to Mr. Meier's expe...
Valeant Grants Schering-Plough Exclusive Option in Japan for Taribavirin in Exchange for Release of Last Right of Refusal
...SO VIEJO, Calif., June 1 /PRNewswire-FirstCall/ -- valeant
Pharmaceuticals International (NYSE: VRX ) annou...r a 2000 agreement, providing more flexibility for valeant
to actively pursue partnering arrangements for the...d.
Under the terms of the option agreement, valeant
granted Schering-Plough the option to enter into a...
Valeant in Medical Technology
Valeant in Biological Technology
DFB Sells Coria Labs to Valeant Pharmaceuticals
FORT WORTH, Texas, Sept. 17 /PRNewswire/ -- H. Paul Dorman, Chairman
and Chief Executive Officer of Fort Worth-based DFB Pharmaceuticals, Inc.,
today announced that DFB has signed a definitive agreement to sell its
dermatology division Coria Laboratories, Ltd. to Valeant
Valeant Pharmaceuticals Reports Encouraging Final Results With Taribavirin Phase IIb Study
...SO VIEJO, Calif., June 1 /PRNewswire-FirstCall/ -- valeant
Pharmaceuticals International (NYSE: VRX ) today...in may be as effective as weight based ribavirin. valeant
plans to present the full final data at the Americ...000 IU/mL and 82.1 kg mean weight.
Valeant Pharmaceuticals Completes Acquisition of Dow Pharmaceutical Sciences, Inc.
...eutical and biotechnology companies.
Pharmaceuticals International (NYSE: VRX ) is a ...neurology and
dermatology. More information about valeant
can be found at
Valeant to Acquire Dow Pharmaceutical Sciences, Inc. for $285 Million
Under the terms of the agreement, valeant
will pay Dow $285 million,
subject to certain clos...ccounts, making the net amount paid $277
will make the first payment of $250 million upon c...ich will be subject to
indemnification claims from valeant
for a period of eighteen months following
Cytopia Strengthens Scientific Team With US-Based Drug Development Specialist
to provide scientific leadership and guidance. He has held global
leadership roles at Glaxo Wellcome and Burroughs Wellcome and in recent
years, at valeant
Pharmaceuticals International and Anadys Pharmaceuticals,
Inc, a company he co-founded.
Holding a Ph.D. in Microbiology and Immunology, Dr. Averett ...
ABT is the Only Source for Kelo-cote(R) Advanced Formula Scar Gel
...onger available under the Dermatix label. Doctors
and customers should not be misled by competitors' claims they offer the
same product. Specifically, valeant
Pharmaceutical's claim that Dermatix
and Dermatix Ultra contain the same formula or an improvement of
Kelo-cote(R) advanced formula scar gel is FALSE....
Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes
... INC (Tokyo SE: 3402) TOYOBO CO (Tokyo SE: 3101) valeant
PHARMACEUTICALS INTL (NYSE: VRX )
HealthShares(...Tokyo SE: 4518) TRANSGENE (Euronext, Paris: TNG) valeant
PHARMACEUTICALS INTL (NYSE: VRX ) VERTEX PHARMAC...X ) SUCAMPO PHARMACEUTICALS INC (NASDAQ: SCMP ) valeant
PHARMACEUTICALS INTL (NYSE: VRX ) XENOPORT INC (...
Senetek PLC Reports First Quarter 2008 Financial Results
...e previously announced grant of a paid up license for Kinetin and Zeatin
Net loss for the quarter ended March 31, 2008 totale...e previously announced grant of a paid up license for Kinetin and
Zeatin to valeant
Pharmaceuticals Inc. and $1,320,000 from settlement of
claims against a pro...
QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)
...GN ) Respironics Inc. (Nasdaq: RESP ) Sepracor Inc. (Nasdaq: SEPR ) Theravance Inc. (Nasdaq: THRX ) United Therapeutics Corp. (Nasdaq: UTHR ) valeant
Pharmaceuticals Int'l (NYSE: VRX ) Vertex Pharmaceuticals (Nasdaq: VRTX ) Add Adolor Corp. (Nasdaq: ADLR ) ALLOS THERAPEUTICS INC. (Nasdaq: AL...
Senetek PLC Announces Appointments of Key Personnel
...s for Glaxo Pharmaceuticals, Inc. In 1997 he became Vice President and
General Manager of North American Operations for ICN Pharmaceuticals, Inc.
Pharmaceuticals). He then went on to become President and CEO
of Obagi Medical Products, a specialty pharmaceutical company focused in